NEW! Conversations on 
Twitter :
-
Back and forth on the surprisingly severe side effects of newer "targeted" cancer drugs
Conversation started by @RyanMFierce -
Brief discussion on the maladies of short-term incentives for pharma CEOs
Based on an article by ex-Pfizer president @john_lamattina
@FierceBiotech: New compound nearly wipes out HIV in cells. More | Release | Follow @FierceBiotech
@JohnCFierce: Sanofi/Regeneron enrolling 22,000 patients for Phase III PCSK9 program. Let the LDL games begin. Release | Follow @JohnCFierce
@RyanMFierce: CHMP has backed approval of gene therapy for 1st time. How big of a 'first' is this in biotech business? Release | Follow @RyanMFierce
> Canadian researchers scrutinized the potential for higher risks of certain side effects from new cancer drugs. Article
> The EMA accepted Pfizer's application for approval of bazedoxifene/conjugated estrogens from partner Ligand Pharmaceuticals ($LGND) for treating estrogen deficiency and osteoporosis in certain women. Item
> Canada-based Nuvo Research says that it expects to collect $6 million in milestone fees from partner Galderma related to Galderma's license to Pliaglis. Release
> Merck Serono failed to satisfy unhappy union members in negotiations about severance to workers affected by the closure of its headquarters in Geneva, Switzerland. News
Pharma News
@FiercePharma: Pfizer foils genericsmakers on Lyrica for 5 years. Last year's sales? $3.7B. Report | Follow @FiercePharma
@EricPFierce: WSJ: J&J, feds reach deal of up to $2.2 billion; J&J to pay $400 million fine but keep selling to federal programs. Story | Follow @EricPFierce
> Did anemia drug giants game the system to rake in billions? Article
> Nacto may next attack Pfizer, Roche drugs with compulsory license. News
> Some docs not so hot on potential for diet drugs Qsymia, Belviq. More
> Pfizer foils genericsmakers on Lyrica for 5 years. Story
@FierceMedDev: Roche Diagnostics plans to roll out a new interactive insulin pump system later this year. Article | Follow @FierceMedDev
@MarkHFierce: What were the top 10 VC medical device deals in H1 2012? Report | Follow @MarkHFierce
> Second Sight to argue for FDA approval of retinal prosthesis. Story
> Study: FDA device recall databases don't collect hacking data. Article
> Kips Bay Medical pursues new IDE for artery graft mesh device. More
> Med device VC deals are rising but the dollar volume remains flat. Report
And Finally… Bloomberg spotlighted Merck's ($MRK) sleeping pill in late-stage development. Item